院長が関わった論文をご紹介します
英文原著論文
1. Sato T., Fuse A., Kuwata T. : Enhancement by interferon of natural cytotoxic activities of lymphocytes from human cord blood and peripheral blood of aged persons.
Cell Immunol. 45 : 458-463,1979
2. Sato T., Tomita T., Kuwata T. : Inhibition by interferon of Sendai virus cytolysis. Infect. Immunity 28 : 6-10, 1980.
3. Chen H.-Y., Sato T., Fuse A., Kuwata T., Conten J. : Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action. J. Gen. Virol. 52 : 177-181, 1981.
4. Fuse A., Sato T., Kuwata T. : Inhibitory effect of cholera toxin on human natural cell-mediated cytotoxicity and its augmentation by interferon. Int. J. Cancer 27 : 19-36, 1981.
5. Sugita K., Sato T., Fuse A., Nakajima H. : The effects of glycolipids and carbohydrates on bilirubin cytotoxicity in vitro. Bio. Neonate 49 : 255-260, 1986.
6. Sunami S., Fuse A., Simizu B., Komori I., Okimoto Y., Sato T., Nkajima H. : The c-myc expression in childhood leukemia and lymphoma. Acta haematol. Jpn. 50 : 109-113, 1987.
7. Miki T., Sato T., Nakajima H., Koyama S., Toyama Y., Fuse A., Suzuki n., Kanno H., Sakamaki T., Kato I. : Retrovirus produced by a lymphoid cell line from an infant with acute lymphoblastic leukemia. Jpn. J. Cancer Res. 78 : 144-152, 1987.
8. Sunami S., Fuse A., Simizu B., Eguchi M., Hayashi H., Sugita K., Nakazawa S., Okimoto Y., Sato T., Nakajima H. : The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down’s syndrome. Blood 70 : 368-371, 1987.
9. Sugita K., Sato T., Nakajima H. : Effects of pH and hypoglycemia on bilirubin cytotoxicity in vitro. Bio. Neonate 52 : 22-25, 1987.
10. Hayashi Yl., Eguchi M., Sugita K., Nakazawa S., Sato T., Kojima S., Bessho F., Konishi S., Inaba T., Hanada R., Ymamoto K. : Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Downís syndrome. Blood 72 : 15-23, 1988
11. Shima Y., Sato T., Nakajima H., Eguchi M., Fuse A., : Inhibition of proliferation and induction of differentiation of a megakaryoblastic leukemia cell line, CMK cells by interferon-γ. In The Biology of the Interferon System 407-411, 1989.
12. Sato T., Fuse A., Eguchi M., Hayashi H., Ryo R., Adachi M., Kishimoto Y., Teramura M., Mizoguchi H., Shima Y., Komori I., Sunami S., Okimoto Y., Nakajima H. : Establishment of a human cell line (CMK) with megakaryocytic characteristics from a Down’s syndrome patient with acute megakaryoblastic leukaemia. Br. J. Haematol. 72 : 184-190, 1989.
13. Eguchi M., Sasakibara H., Suda J., Ozawa T., Hayashi Y., Sato T., Kojima S., Furukawa T. : Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down’s syndrome. Blood 74 : 42-48, 1989.
14. Komatsu N., Suda T., Moroi M., Tokuyama N., Sakata Y., Okada Y., Sato T., Fuse A., Nishida T., Hirai Y., Miura Y. : Growth and differentiation of a human megakaryoblastic cell line, CMK. Blood 74 : 42-48, 1989.
15. Adachi M., Ryo R., Yoshida A., Teshigawara K., Yamaguchi N., Hoshijima M., Takai Y., Sato T. : Elevation of intracellular calcium iron by prostagrandin E and its inhibition by protein kinase C in human megakaryocyte leukemia cell line. Cancer Res. 49 : 3805-3808, 1989.
16. Ryo R., Yoshida A., Adachi M., Sugano W., Yasunaga M., Yoneda N., Yamaguchi N., Sato T. : Cytosolic Calcium mobilization and thromboxane synthesis in a human megakaryocytic leukemia cell. Exp. Hematol. 18 : 271-275, 1990.
17. Kojima S., Matsuyama T., Sato T., Horibe K., Konishi S., Tsuchida M., Hayashi Y., Kigasawa H., Akiyama Y., Okamura J., Nakahata T., Bessho F., Eguchi M., Nakazawa S., Uedaa R. : Downís syndrome and acute leukemia in children :An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 11 : 2348-2353, 1990.
18. Ishii E., Okamura J., Tsuchida M., Kobayashi M., Akiyama Y., Nakahata T., Kojima S., Hanada R., Horibe K., Sato T., Komada Y., Kimura K., Sakaguchi C., Hosoya R., Oda M., Tsunematsu Y., Kawa K., Konishi S., Tsukimoto I., Matsuyama K., Ueda K. : Infant leukemia in Japan : Clinical and biological analysis of 48 cases. Medical and Pediatric Oncology 19 : 28-32, 1991.
19. Sakaguchi M., Sato T., Groopman JE. : Human immunodeficiency virus infection of megakaryocytic cells. Blood 77 : 481-485, 1991.
20. Fuse A., Kakuda H., Shima Y., Damme J.V., Billiau A., Sato T. : Inteleukin 6, possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br. J. Haematol. 77 : 32-36, 1991.
21. Tsuchiba M., Akatsuka J., Bessho F., Chihara H., Hayashi Y., Hoshi Y., Hosoya R., Furukawa T., Ikuta K., Inana I., Ishikawa A., IshimotoK., Ito K., Kaneko M., Kaneko T., Kato S., Komiyama J., Matsuyama S., Nagao T., Nakazawa S., Nishihara K., Ohira M., Okimoto Y., Ohkawa Y., Ohtsuki H., Sato T., Shibuya A., Shitara T., Sugita K., Taguchi N., Torigoe K., Tsukada M., Tsukimoto I., Tsunematsu Y., Wada E., Yamada K., Yamada K., Yamamoto K., Yamamoto M., Yata J., Nishimura K.,and Saito T. : Treatment of acute lymphoblastic leukemia in Tokyo Children’s Cancer Study Group-Preliminary results of L84-11 protocol. Acta Paediatr. Jpn. 33 : 522-532, 1991.
22. Tsuda E., Kawanishi G., Ueda M., Sato T., Suda T., Miura Y., Sasaki R. : Factor with erythroid burst-promoting activity in human urine unlike other hematopoietic growth factors. Int. J. Hmatol. 54 : 363-369, 1991.
23. Hamamoto K, Ohga S., Taniguchi H., Nagano T., Kitajima H., Kishimoto Y., Kimura T., Fygitake H., Ymauchi M., Yasunaga K., Sato T. : The distribution of thrombospondin in platelet and megakaryocyte by cryo-ultramicrotomy. J. Clin. Electron Microscopy 25 : 5-6, 1991.
24. Adachi M., Ryo R., Sato T., Yamaguchi N. : Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK 11-5). Exp Hematol. 19 : 923-7, 1991.
25. Nagano N., Ohga S., Kishimoto Y., Kimura T., Yasunaga K., Adachi M., Ryo R., Sato T. : Ultrastructural analysis of platelet-like particles from a human megakaryocytic leukemia cell line (CMK11-5). Int. J. Hematol. 56 : 67-76, 1992.
26. Adachi M., Ryo R., Yoshida A., Sugano W., Yasunaga M., Saigo K., Yamaguchi N., Sato T., Sano K., Kaibuchi K., Takai Y. : Induction of amg p21/rap1A p21/krev-1 p21gene expression during phorbol ester-induced differentiation of a human megakaryocytic leukemia cell line. Oncogene 7 : 323-329, 1992.
27. Iida S., Yoshida T., Naito K., Sakamoto H., Katoh O., Hirohashi H., Sato T., Onda M., Sugimura T., Terada M. : Human hst-2(FGF-6) oncogene : cDNA cloning and characterization. Oncogene 7 : 303-309, 1992.
28. katoh O., Hattori Y., Sato T., Kimura A., Kuramato A., Sugimura T., Terada M. : Expression of the heparin-binding growth factor receptor gene in human megakaryocytic leukemia cells. BBRC 183 : 83-92, 1992.
29. Akiyama Y., Yamaguchi K., Sato T., Abe K. : Tumor necrosis factor-α stimulates colony formation by a megakaryoblastic leukemia cell line, CMK. Jpn. J. Cancer Res. 83 : 989-994, 1992.
30. Miura K., Teramura M., Hoshino S., Mizoguchi H., Sato T. : Stimulatory effect of tumor necrosis factor-αon the growth of CMK, a human megakaryoblastic leukemia cell line. Leukemia Res. 16 : 281-285, 1992.
31. Moroi M., Ohnuma M., Komatsu N., Miura Y., Sato T., Jung S.M. : Phorbol ester treatment of two megakaryoblastic cell lines, CMK and UT-7, induces specific protein composition changes with non-coincident time-courses. Biochimica et Biophysica Acta. 1177 : 139-146, 1993.
32. Hamamoto K., Ohga S., Nagano T., kishimoto Y., Yasunaga K., Sato T. : Expression of platelet alpha-granule proteins in a human megakaryocytic leukemia cell line (CMK 11-5). Int. J. Hematol. 58 : 105-112, 1993.
33. Tsukada M., Komiyama A., Nakazawa S., Tsuchida M., Nishihira H., Shitara T., Ohira M., Tsunematsu Y., Yamamoto K., Hoshi Y., Yamada K., Hosoya R., Sato T., Bessho F., Tsukimoto I., Yamamoto M., Ikuta K., Saito T., Nishimura K. and the Tokyo Children Cancer Study Group : Treatment of standard risk acute lymphoblastic leukemia in children with the Tokyo Children Cancer Study Group (TCCSG) L84-11 protocol in Japan. Int. J. Hematol. 57 : 1-7, 1993.
34. Nagano T., KishimotoY., Sato T. et al. : Ultrastructural analysis of a human megakaryocytic leukemia cell line (CMK 11-5) in response to platelet agonist. Int. J. Hematol. 57 : 73-80, 1993.
35. Akiyama N., Sato T., Terada M. et al. : Increment of the cyclin D1 mRNA level in TPA-treated three human myeloid leukemia cell lines : HEL,CMK and Iil-60cells. BBRC. 195 : 1041-1049, 1993.
36. Hoshi M., Nagasawa T., Abe T., Sato T., Mitsui Y. : Maturation of human megakaryocytic cell line (CMK-7) on the human umbilical vein endothelial cell (EC) monolayer. Int. J. Hematol. 59(3) : 191-9, 1994.
37. Sato T., Ota S., Kakuda H., Miura N., Niimi H., Ito M., Asai T., Tsuruo T., Fuse A. : Expression of multidrug resistant gene (mdr-1/P-glycoprotein) in a megakaryoblastic cell line, CMK, and its enhancement during megakaryoblastic differentiation. Leuk. Lymph. 18 : 515-520, 1995.
38. Ota S., Sato T., Kakuda H., Hiranok K., Okimoto Y., Mori T., Nakazawa S., Kojima S., Matsuyama T., Tsuruo T., Fuse A., Niimi H. : Expression of mdr-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells. Leuk. Lymph. 19 : 431-436, 1995.
39. Kakuda H., Sato T., Hayashi Y., Enomoto Y., Takayama J., Ohira M., Seto M., Ueda R., Fuse A., Niimi H. : A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells. Br. J. Haematol. 95 : 306-318, 1996.
40. Watanabe T., Wang X.L., Miyakawa A. Shiba M., Imai Y., Sato T., Tanzawa H. : Mutational state of tumor suppressor genes (DCC,DPC4) and alteration on chromosome 18q21 in human oral cancer. International Journal of Oncology 11 : 1287-1290, 1997.
41. Joh T., Yamamoto K., Kagami Y., Kakuda H., Sato T., Yamamoto T., Takahashi T., Ueda R., Kaibuchi K. and Seto M. : Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus. Oncogene 15 : 1681-1687, 1997.
42. Yokoe H, Masumi-Fukazawa A, Sunohara M, Tanzawa H, Sato K, Sato T, Fuse A. : Induction of polyploidization in the human erythroleukemia cell line (HEL) by the protein kinase inhibitor (K252a) and the phorborlester-TPA. Leuk. Lymph. 25: 333-343,1997
43. Suzuki T, Watanabe K, Kanaoka Y, Sato T, Hayaishi O. : Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester. Biochem Biophys Res Commun. 241 : 288-293, 1997.
44. Hagiwara S, Sato T, Itoh Y. : Effects of recombinant human interleukin-3 on maturation of megakaryocytic cell line, CMK. Leuk Res. 21 : 153-162, 1997.
45. Wang XL, Uzawa K, Miyakawa A, Shiiba M, Watanabe T, Sato T, Miya T, Yokoe H, Tanzawa H. : Localization of a tumour-suppressor gene associated with human oral cancer on 7q31.1. Int J Cancer. 75 : 671-674, 1998.
46. Ogawara K, Miyakawa A, Shiba M, Uzawa K, Watanabe T, Wang XL, Sato T, Kubosawa H, Kondo Y, Tanzawa H. : Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int J Cancer. 79 : 312-317, 1998.
47. Sato T, Fuse A, Niimi H, Fielder PJ, Avraham H. : Binding and regulation of thrombopoietin to human megakaryocytes. Br J Haematol. 100 : 704-711, 1998.
48. Miura N, Sato T, Fuse A, Okimoto Y, Kinugawa N, Horie H, Ota S, Kakuda H, Yokoe H, Miya T, Suzuki N, Niimi H. : Establishment of a new human megakaryoblastic cell line, CMY, with chromosome 17p abnormalities. Int J Mol Med. 1 : 559-563, 1998.
49. Miura N, Terai M, Meng YG, Sato T, Niimi H. : Serum thrombopoietin levels in Kawasaki disease. Br J Haematol. 100 : 387-388, 1998.
50. Kinugawa N, Imashuku S, Hirota Y, Yamada K, Yamamoto A, Akazai A, Oda M, Miura N, Kakuta H, Sato T, Endo M, Takano T. : Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant. 24 : 935-938, 1999.
51. Hirano K, Kondo F, Kondo Y, Kurosawa K, Suwabe S, Noguchi Y, Miura N, Kakuda H, Sato T, Niimi H.(Corresponding author) : Stool smears for diagnosis of intestinal acute graft-versus-host disease. Bone Marrow Transplant. 24 : 799-801, 1999.
52. Toyoda Y, Manabe A, Tsuchida M, Hanada R, Ikuta K, Okimoto Y, Ohara A, Ohkawa Y, Mori T, Ishimoto K, Sato T, Kaneko T, Maeda M, Koike K, Shitara T, Hoshi Y, Hosoya R, Tsunematsu Y, Bessho F, Nakazawa S, Saito T. : Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood. J Clin Oncol. 18 : 1508-1516, 2000.
53. Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K, Toyoda Y, Manabe A, Koike K, Kinoshita A, Maeda M, Ishimoto K, Sato T, Okimoto Y, Kaneko T, Kajiwara M, Sotomatsu M, Hayashi Y, Yabe H, Hosoya R, Hoshi Y, Ohira M, Bessho F, Tsunematsu Y, Tsukimoto I, Nakazawa S. : Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children’s Cancer Study Group 1981-1995. Leukemia. 14 : 2295-2306, 2000.
54. Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M, Saito H, Kojima S, Matsuyama T, Kitaori K, Nagafuji K, Sato T, Kodera Y. : Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant. 25 : 545-548, 2000.
55. Sato T, Sekine H, Kakuda H, Miura N, Sunohara M, Fuse A. : HIV infection of megakaryocytic cell lines. Leuk Lymphoma. 36 : 397-404, 2000.
56. Kojima s, Sako M, Kato K, Hosoi G, Sato T, Ohara A, Koike K, Okimoto Y, Nishimura S, Akiyama Y, Yoshikawa T, Ishii E, Okamura J, Yazaki M, Hayashi Y, Eguchi M, Tsukimoto I, Ueda K. : An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down’s syndrome. Leukemia. 2000 May;14(5):786-91.
57. Fuse A, Aoki Y, Sato T, Kita M, Yamamoto T, Toriizuka K, Sunohara M, Takeoka H. : Effect of gravity change on the production of thrombopoietic growth factors. Biol Sci Space. 15 : 302-303, 2001.
58. Fuse A, Sato T. : Effect of gravity change on thrombopoiesis in mice. J Gravit Physiol. 8 : 63-64, 2001.
59. Manabe A, Tsuchida M, Hanada R, Ikuta K, Toyoda Y, Okimoto Y, Ishimoto K, Okawa H, Ohara A, Kaneko T, Koike K, Sato T, Sugita K, Bessho F, Hoshi Y, Maeda M, Kinoshita A, Saito T, Tsunematsu Y, Nakazawa S. : Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children’s Cancer Study Group study L89-12. J Clin Oncol. 19 : 3182-3187, 2001.
60. Fuse A, Aoki Y, Sato T, Sunohara M, Takeoka H. : Decreased platelet level in peripheral blood of mice by microgravity. Biol Sci Space. 16 : 159-160, 2002.
61. Sunohara M, Morikawa S, Sato T, Sato I, Sato T, Fuse A. : Modulation of human c-mpl gene expression by thrombopoietin through protein kinase C. Cell Mol Biol (Noisy-le-grand). 49 Online Pub:OL393-8, 2003.
62. Sakao E, Ishihara A, Horikawa K, Akiyama M, Arai M, Kato M, Seki N, Fukunaga K, Shimizu-Yabe A, Iwase K, Ohtsuka S, Sato T, Kohno Y, Shibata S, Takiguchi M. : Two-peaked synchronization in day/night expression rhythms of the fibrinogen gene cluster in the mouse liver. J Biol Chem. 278 : 30450-30457, 2003.
63. Fuse A, Sato T. : Effect of microgravity changes on virus infection in mice. J Gravit Physiol. 2004 Jul;11(2):P65-6.
64. Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E. : Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 104 : 3527-3534, 2004.
65. Igari H, Watanabe T, Sato T. : Booster phenomenon of quantiFERON-TB Gold after prior intradermal PPD injection. Int. J. Tuberc. Lung Dis. 11:788-791, 2007.
66. Nakamura H, Sato T, Okada K, Miura G, Ariyoshi N, Makazawa K and Kitada M: Population pharmacokinetics of oral busulfan in young Japanese children before hematopoietic stem cell transplantation. Ther Drug Monit. 30:75-83,2008
67. Sunohara M, Morikawa S, Sato T, Miyado M, Sato I, Sato T, Fuse A. : Promoter regulatory motifs involved in c-mpl gene expression induced by PMA. Cell Biol Int. Jun;32(6):692-697. Epub 2008 Jan 25. 2008
68. Sunohara M, Morikawa S, Sato T, Miyado M, Sato I, Sato T, Fuse A. : Promoter regulatory motifs involved in c-mpl gene expression induced by PMA. Cell Biol Int. Jun;32(6):692-697. Epub 2008 Jan 25. 2008
69. Nakamura H, Sato T, Okada K, Miura G, Ariyoshi N, Makazawa K and Kitada M: Population pharmacokinetics of oral busulfan in young Japanese children before hematopoietic stem cell transplantation. Ther Drug Monit. 30:75-83,2008
70. Igari A, Watanabe T, Sato T. : Booster phenomenon of quantiFERON-TB Gold after prior intradermal PPD injection. Int. J. Tuberc. Lung Dis. 11:788-791, 2007.
71. Igari H, Segawa S, Watanabe A, Suzuki A, Watanabe M, Sakurai T, Kuroda F, Watanabe M, Tatsumi K, Nakayama M, Nakayama T, Suzuki K, Sato T: Immunogenicity of a Monovalent Pandemic Influenza AH1N1 Vaccine in Health Care Workers of a University Hospital in Japan. Microbiol Immunol 2010;54: 618–624.
2. Sato T., Tomita T., Kuwata T. : Inhibition by interferon of Sendai virus cytolysis. Infect. Immunity 28 : 6-10, 1980.
3. Chen H.-Y., Sato T., Fuse A., Kuwata T., Conten J. : Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action. J. Gen. Virol. 52 : 177-181, 1981.
4. Fuse A., Sato T., Kuwata T. : Inhibitory effect of cholera toxin on human natural cell-mediated cytotoxicity and its augmentation by interferon. Int. J. Cancer 27 : 19-36, 1981.
5. Sugita K., Sato T., Fuse A., Nakajima H. : The effects of glycolipids and carbohydrates on bilirubin cytotoxicity in vitro. Bio. Neonate 49 : 255-260, 1986.
6. Sunami S., Fuse A., Simizu B., Komori I., Okimoto Y., Sato T., Nkajima H. : The c-myc expression in childhood leukemia and lymphoma. Acta haematol. Jpn. 50 : 109-113, 1987.
7. Miki T., Sato T., Nakajima H., Koyama S., Toyama Y., Fuse A., Suzuki n., Kanno H., Sakamaki T., Kato I. : Retrovirus produced by a lymphoid cell line from an infant with acute lymphoblastic leukemia. Jpn. J. Cancer Res. 78 : 144-152, 1987.
8. Sunami S., Fuse A., Simizu B., Eguchi M., Hayashi H., Sugita K., Nakazawa S., Okimoto Y., Sato T., Nakajima H. : The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down’s syndrome. Blood 70 : 368-371, 1987.
9. Sugita K., Sato T., Nakajima H. : Effects of pH and hypoglycemia on bilirubin cytotoxicity in vitro. Bio. Neonate 52 : 22-25, 1987.
10. Hayashi Yl., Eguchi M., Sugita K., Nakazawa S., Sato T., Kojima S., Bessho F., Konishi S., Inaba T., Hanada R., Ymamoto K. : Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Downís syndrome. Blood 72 : 15-23, 1988
11. Shima Y., Sato T., Nakajima H., Eguchi M., Fuse A., : Inhibition of proliferation and induction of differentiation of a megakaryoblastic leukemia cell line, CMK cells by interferon-γ. In The Biology of the Interferon System 407-411, 1989.
12. Sato T., Fuse A., Eguchi M., Hayashi H., Ryo R., Adachi M., Kishimoto Y., Teramura M., Mizoguchi H., Shima Y., Komori I., Sunami S., Okimoto Y., Nakajima H. : Establishment of a human cell line (CMK) with megakaryocytic characteristics from a Down’s syndrome patient with acute megakaryoblastic leukaemia. Br. J. Haematol. 72 : 184-190, 1989.
13. Eguchi M., Sasakibara H., Suda J., Ozawa T., Hayashi Y., Sato T., Kojima S., Furukawa T. : Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down’s syndrome. Blood 74 : 42-48, 1989.
14. Komatsu N., Suda T., Moroi M., Tokuyama N., Sakata Y., Okada Y., Sato T., Fuse A., Nishida T., Hirai Y., Miura Y. : Growth and differentiation of a human megakaryoblastic cell line, CMK. Blood 74 : 42-48, 1989.
15. Adachi M., Ryo R., Yoshida A., Teshigawara K., Yamaguchi N., Hoshijima M., Takai Y., Sato T. : Elevation of intracellular calcium iron by prostagrandin E and its inhibition by protein kinase C in human megakaryocyte leukemia cell line. Cancer Res. 49 : 3805-3808, 1989.
16. Ryo R., Yoshida A., Adachi M., Sugano W., Yasunaga M., Yoneda N., Yamaguchi N., Sato T. : Cytosolic Calcium mobilization and thromboxane synthesis in a human megakaryocytic leukemia cell. Exp. Hematol. 18 : 271-275, 1990.
17. Kojima S., Matsuyama T., Sato T., Horibe K., Konishi S., Tsuchida M., Hayashi Y., Kigasawa H., Akiyama Y., Okamura J., Nakahata T., Bessho F., Eguchi M., Nakazawa S., Uedaa R. : Downís syndrome and acute leukemia in children :An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 11 : 2348-2353, 1990.
18. Ishii E., Okamura J., Tsuchida M., Kobayashi M., Akiyama Y., Nakahata T., Kojima S., Hanada R., Horibe K., Sato T., Komada Y., Kimura K., Sakaguchi C., Hosoya R., Oda M., Tsunematsu Y., Kawa K., Konishi S., Tsukimoto I., Matsuyama K., Ueda K. : Infant leukemia in Japan : Clinical and biological analysis of 48 cases. Medical and Pediatric Oncology 19 : 28-32, 1991.
19. Sakaguchi M., Sato T., Groopman JE. : Human immunodeficiency virus infection of megakaryocytic cells. Blood 77 : 481-485, 1991.
20. Fuse A., Kakuda H., Shima Y., Damme J.V., Billiau A., Sato T. : Inteleukin 6, possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK. Br. J. Haematol. 77 : 32-36, 1991.
21. Tsuchiba M., Akatsuka J., Bessho F., Chihara H., Hayashi Y., Hoshi Y., Hosoya R., Furukawa T., Ikuta K., Inana I., Ishikawa A., IshimotoK., Ito K., Kaneko M., Kaneko T., Kato S., Komiyama J., Matsuyama S., Nagao T., Nakazawa S., Nishihara K., Ohira M., Okimoto Y., Ohkawa Y., Ohtsuki H., Sato T., Shibuya A., Shitara T., Sugita K., Taguchi N., Torigoe K., Tsukada M., Tsukimoto I., Tsunematsu Y., Wada E., Yamada K., Yamada K., Yamamoto K., Yamamoto M., Yata J., Nishimura K.,and Saito T. : Treatment of acute lymphoblastic leukemia in Tokyo Children’s Cancer Study Group-Preliminary results of L84-11 protocol. Acta Paediatr. Jpn. 33 : 522-532, 1991.
22. Tsuda E., Kawanishi G., Ueda M., Sato T., Suda T., Miura Y., Sasaki R. : Factor with erythroid burst-promoting activity in human urine unlike other hematopoietic growth factors. Int. J. Hmatol. 54 : 363-369, 1991.
23. Hamamoto K, Ohga S., Taniguchi H., Nagano T., Kitajima H., Kishimoto Y., Kimura T., Fygitake H., Ymauchi M., Yasunaga K., Sato T. : The distribution of thrombospondin in platelet and megakaryocyte by cryo-ultramicrotomy. J. Clin. Electron Microscopy 25 : 5-6, 1991.
24. Adachi M., Ryo R., Sato T., Yamaguchi N. : Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK 11-5). Exp Hematol. 19 : 923-7, 1991.
25. Nagano N., Ohga S., Kishimoto Y., Kimura T., Yasunaga K., Adachi M., Ryo R., Sato T. : Ultrastructural analysis of platelet-like particles from a human megakaryocytic leukemia cell line (CMK11-5). Int. J. Hematol. 56 : 67-76, 1992.
26. Adachi M., Ryo R., Yoshida A., Sugano W., Yasunaga M., Saigo K., Yamaguchi N., Sato T., Sano K., Kaibuchi K., Takai Y. : Induction of amg p21/rap1A p21/krev-1 p21gene expression during phorbol ester-induced differentiation of a human megakaryocytic leukemia cell line. Oncogene 7 : 323-329, 1992.
27. Iida S., Yoshida T., Naito K., Sakamoto H., Katoh O., Hirohashi H., Sato T., Onda M., Sugimura T., Terada M. : Human hst-2(FGF-6) oncogene : cDNA cloning and characterization. Oncogene 7 : 303-309, 1992.
28. katoh O., Hattori Y., Sato T., Kimura A., Kuramato A., Sugimura T., Terada M. : Expression of the heparin-binding growth factor receptor gene in human megakaryocytic leukemia cells. BBRC 183 : 83-92, 1992.
29. Akiyama Y., Yamaguchi K., Sato T., Abe K. : Tumor necrosis factor-α stimulates colony formation by a megakaryoblastic leukemia cell line, CMK. Jpn. J. Cancer Res. 83 : 989-994, 1992.
30. Miura K., Teramura M., Hoshino S., Mizoguchi H., Sato T. : Stimulatory effect of tumor necrosis factor-αon the growth of CMK, a human megakaryoblastic leukemia cell line. Leukemia Res. 16 : 281-285, 1992.
31. Moroi M., Ohnuma M., Komatsu N., Miura Y., Sato T., Jung S.M. : Phorbol ester treatment of two megakaryoblastic cell lines, CMK and UT-7, induces specific protein composition changes with non-coincident time-courses. Biochimica et Biophysica Acta. 1177 : 139-146, 1993.
32. Hamamoto K., Ohga S., Nagano T., kishimoto Y., Yasunaga K., Sato T. : Expression of platelet alpha-granule proteins in a human megakaryocytic leukemia cell line (CMK 11-5). Int. J. Hematol. 58 : 105-112, 1993.
33. Tsukada M., Komiyama A., Nakazawa S., Tsuchida M., Nishihira H., Shitara T., Ohira M., Tsunematsu Y., Yamamoto K., Hoshi Y., Yamada K., Hosoya R., Sato T., Bessho F., Tsukimoto I., Yamamoto M., Ikuta K., Saito T., Nishimura K. and the Tokyo Children Cancer Study Group : Treatment of standard risk acute lymphoblastic leukemia in children with the Tokyo Children Cancer Study Group (TCCSG) L84-11 protocol in Japan. Int. J. Hematol. 57 : 1-7, 1993.
34. Nagano T., KishimotoY., Sato T. et al. : Ultrastructural analysis of a human megakaryocytic leukemia cell line (CMK 11-5) in response to platelet agonist. Int. J. Hematol. 57 : 73-80, 1993.
35. Akiyama N., Sato T., Terada M. et al. : Increment of the cyclin D1 mRNA level in TPA-treated three human myeloid leukemia cell lines : HEL,CMK and Iil-60cells. BBRC. 195 : 1041-1049, 1993.
36. Hoshi M., Nagasawa T., Abe T., Sato T., Mitsui Y. : Maturation of human megakaryocytic cell line (CMK-7) on the human umbilical vein endothelial cell (EC) monolayer. Int. J. Hematol. 59(3) : 191-9, 1994.
37. Sato T., Ota S., Kakuda H., Miura N., Niimi H., Ito M., Asai T., Tsuruo T., Fuse A. : Expression of multidrug resistant gene (mdr-1/P-glycoprotein) in a megakaryoblastic cell line, CMK, and its enhancement during megakaryoblastic differentiation. Leuk. Lymph. 18 : 515-520, 1995.
38. Ota S., Sato T., Kakuda H., Hiranok K., Okimoto Y., Mori T., Nakazawa S., Kojima S., Matsuyama T., Tsuruo T., Fuse A., Niimi H. : Expression of mdr-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells. Leuk. Lymph. 19 : 431-436, 1995.
39. Kakuda H., Sato T., Hayashi Y., Enomoto Y., Takayama J., Ohira M., Seto M., Ueda R., Fuse A., Niimi H. : A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells. Br. J. Haematol. 95 : 306-318, 1996.
40. Watanabe T., Wang X.L., Miyakawa A. Shiba M., Imai Y., Sato T., Tanzawa H. : Mutational state of tumor suppressor genes (DCC,DPC4) and alteration on chromosome 18q21 in human oral cancer. International Journal of Oncology 11 : 1287-1290, 1997.
41. Joh T., Yamamoto K., Kagami Y., Kakuda H., Sato T., Yamamoto T., Takahashi T., Ueda R., Kaibuchi K. and Seto M. : Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus. Oncogene 15 : 1681-1687, 1997.
42. Yokoe H, Masumi-Fukazawa A, Sunohara M, Tanzawa H, Sato K, Sato T, Fuse A. : Induction of polyploidization in the human erythroleukemia cell line (HEL) by the protein kinase inhibitor (K252a) and the phorborlester-TPA. Leuk. Lymph. 25: 333-343,1997
43. Suzuki T, Watanabe K, Kanaoka Y, Sato T, Hayaishi O. : Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester. Biochem Biophys Res Commun. 241 : 288-293, 1997.
44. Hagiwara S, Sato T, Itoh Y. : Effects of recombinant human interleukin-3 on maturation of megakaryocytic cell line, CMK. Leuk Res. 21 : 153-162, 1997.
45. Wang XL, Uzawa K, Miyakawa A, Shiiba M, Watanabe T, Sato T, Miya T, Yokoe H, Tanzawa H. : Localization of a tumour-suppressor gene associated with human oral cancer on 7q31.1. Int J Cancer. 75 : 671-674, 1998.
46. Ogawara K, Miyakawa A, Shiba M, Uzawa K, Watanabe T, Wang XL, Sato T, Kubosawa H, Kondo Y, Tanzawa H. : Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int J Cancer. 79 : 312-317, 1998.
47. Sato T, Fuse A, Niimi H, Fielder PJ, Avraham H. : Binding and regulation of thrombopoietin to human megakaryocytes. Br J Haematol. 100 : 704-711, 1998.
48. Miura N, Sato T, Fuse A, Okimoto Y, Kinugawa N, Horie H, Ota S, Kakuda H, Yokoe H, Miya T, Suzuki N, Niimi H. : Establishment of a new human megakaryoblastic cell line, CMY, with chromosome 17p abnormalities. Int J Mol Med. 1 : 559-563, 1998.
49. Miura N, Terai M, Meng YG, Sato T, Niimi H. : Serum thrombopoietin levels in Kawasaki disease. Br J Haematol. 100 : 387-388, 1998.
50. Kinugawa N, Imashuku S, Hirota Y, Yamada K, Yamamoto A, Akazai A, Oda M, Miura N, Kakuta H, Sato T, Endo M, Takano T. : Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant. 24 : 935-938, 1999.
51. Hirano K, Kondo F, Kondo Y, Kurosawa K, Suwabe S, Noguchi Y, Miura N, Kakuda H, Sato T, Niimi H.(Corresponding author) : Stool smears for diagnosis of intestinal acute graft-versus-host disease. Bone Marrow Transplant. 24 : 799-801, 1999.
52. Toyoda Y, Manabe A, Tsuchida M, Hanada R, Ikuta K, Okimoto Y, Ohara A, Ohkawa Y, Mori T, Ishimoto K, Sato T, Kaneko T, Maeda M, Koike K, Shitara T, Hoshi Y, Hosoya R, Tsunematsu Y, Bessho F, Nakazawa S, Saito T. : Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood. J Clin Oncol. 18 : 1508-1516, 2000.
53. Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K, Toyoda Y, Manabe A, Koike K, Kinoshita A, Maeda M, Ishimoto K, Sato T, Okimoto Y, Kaneko T, Kajiwara M, Sotomatsu M, Hayashi Y, Yabe H, Hosoya R, Hoshi Y, Ohira M, Bessho F, Tsunematsu Y, Tsukimoto I, Nakazawa S. : Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children’s Cancer Study Group 1981-1995. Leukemia. 14 : 2295-2306, 2000.
54. Miyamura K, Hamaguchi M, Taji H, Kanie T, Kohno A, Tanimoto M, Saito H, Kojima S, Matsuyama T, Kitaori K, Nagafuji K, Sato T, Kodera Y. : Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant. 25 : 545-548, 2000.
55. Sato T, Sekine H, Kakuda H, Miura N, Sunohara M, Fuse A. : HIV infection of megakaryocytic cell lines. Leuk Lymphoma. 36 : 397-404, 2000.
56. Kojima s, Sako M, Kato K, Hosoi G, Sato T, Ohara A, Koike K, Okimoto Y, Nishimura S, Akiyama Y, Yoshikawa T, Ishii E, Okamura J, Yazaki M, Hayashi Y, Eguchi M, Tsukimoto I, Ueda K. : An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down’s syndrome. Leukemia. 2000 May;14(5):786-91.
57. Fuse A, Aoki Y, Sato T, Kita M, Yamamoto T, Toriizuka K, Sunohara M, Takeoka H. : Effect of gravity change on the production of thrombopoietic growth factors. Biol Sci Space. 15 : 302-303, 2001.
58. Fuse A, Sato T. : Effect of gravity change on thrombopoiesis in mice. J Gravit Physiol. 8 : 63-64, 2001.
59. Manabe A, Tsuchida M, Hanada R, Ikuta K, Toyoda Y, Okimoto Y, Ishimoto K, Okawa H, Ohara A, Kaneko T, Koike K, Sato T, Sugita K, Bessho F, Hoshi Y, Maeda M, Kinoshita A, Saito T, Tsunematsu Y, Nakazawa S. : Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children’s Cancer Study Group study L89-12. J Clin Oncol. 19 : 3182-3187, 2001.
60. Fuse A, Aoki Y, Sato T, Sunohara M, Takeoka H. : Decreased platelet level in peripheral blood of mice by microgravity. Biol Sci Space. 16 : 159-160, 2002.
61. Sunohara M, Morikawa S, Sato T, Sato I, Sato T, Fuse A. : Modulation of human c-mpl gene expression by thrombopoietin through protein kinase C. Cell Mol Biol (Noisy-le-grand). 49 Online Pub:OL393-8, 2003.
62. Sakao E, Ishihara A, Horikawa K, Akiyama M, Arai M, Kato M, Seki N, Fukunaga K, Shimizu-Yabe A, Iwase K, Ohtsuka S, Sato T, Kohno Y, Shibata S, Takiguchi M. : Two-peaked synchronization in day/night expression rhythms of the fibrinogen gene cluster in the mouse liver. J Biol Chem. 278 : 30450-30457, 2003.
63. Fuse A, Sato T. : Effect of microgravity changes on virus infection in mice. J Gravit Physiol. 2004 Jul;11(2):P65-6.
64. Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E. : Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 104 : 3527-3534, 2004.
65. Igari H, Watanabe T, Sato T. : Booster phenomenon of quantiFERON-TB Gold after prior intradermal PPD injection. Int. J. Tuberc. Lung Dis. 11:788-791, 2007.
66. Nakamura H, Sato T, Okada K, Miura G, Ariyoshi N, Makazawa K and Kitada M: Population pharmacokinetics of oral busulfan in young Japanese children before hematopoietic stem cell transplantation. Ther Drug Monit. 30:75-83,2008
67. Sunohara M, Morikawa S, Sato T, Miyado M, Sato I, Sato T, Fuse A. : Promoter regulatory motifs involved in c-mpl gene expression induced by PMA. Cell Biol Int. Jun;32(6):692-697. Epub 2008 Jan 25. 2008
68. Sunohara M, Morikawa S, Sato T, Miyado M, Sato I, Sato T, Fuse A. : Promoter regulatory motifs involved in c-mpl gene expression induced by PMA. Cell Biol Int. Jun;32(6):692-697. Epub 2008 Jan 25. 2008
69. Nakamura H, Sato T, Okada K, Miura G, Ariyoshi N, Makazawa K and Kitada M: Population pharmacokinetics of oral busulfan in young Japanese children before hematopoietic stem cell transplantation. Ther Drug Monit. 30:75-83,2008
70. Igari A, Watanabe T, Sato T. : Booster phenomenon of quantiFERON-TB Gold after prior intradermal PPD injection. Int. J. Tuberc. Lung Dis. 11:788-791, 2007.
71. Igari H, Segawa S, Watanabe A, Suzuki A, Watanabe M, Sakurai T, Kuroda F, Watanabe M, Tatsumi K, Nakayama M, Nakayama T, Suzuki K, Sato T: Immunogenicity of a Monovalent Pandemic Influenza AH1N1 Vaccine in Health Care Workers of a University Hospital in Japan. Microbiol Immunol 2010;54: 618–624.
※日本語の論文等については現在整理中
